[Rofecoxib and gynecomastia: the first case].
Schmutz
J-L
JL
Service de Dermatologie, Hôpital Fournier, 36 quai de la Bataille, 54035 Nancy Cedex, France.
Barbaud
A
A
Trechot
P
P
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib